Aurinia to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announces participation in upcoming investor conferences in March 2024, including TD Cowen’s 44th Annual Health Care Conference and Leerink Partners Global Biopharma Conference. Management will engage in one-on-one meetings, fireside chats, and Q&A sessions to discuss the company's progress and future plans.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that management will be participating in the following upcoming investor conferences during the month of March:

• TD Cowen’s 44th Annual Health Care Conference taking place March 4 - 6, 2024, at the Marriott Copley Place in Boston, MA. Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, March 5, from 1:30-2:00 PM Eastern Time. A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here.

• Leerink Partners Global Biopharma Conference taking place March 11-13, 2024, at the Fontainebleau Miami Beach. Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, March 12, from 8:40 – 9:10 AM Eastern Time. The session will not include a webcast.

About Aurinia
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS^® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227383351/en/

Media and Investor Inquiries:

Andrea Christopher

Corporate Communications and Investor Relations, Aurinia

achristopher@auriniapharma.com

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When is Aurinia Pharmaceuticals participating in investor conferences in March 2024?

Aurinia Pharmaceuticals is participating in TD Cowen’s 44th Annual Health Care Conference from March 4 - 6, 2024, and Leerink Partners Global Biopharma Conference from March 11-13, 2024.

What will Aurinia management do at the conferences?

Aurinia management will engage in one-on-one meetings with investors, participate in fireside chats, and host Q&A sessions to discuss the company's progress and future plans.

Where can investors watch the live webcast of the session on March 5?

Investors can watch the live webcast of the session on March 5 on the Investor section of Aurinia’s website.

Will the session at Leerink Partners Global Biopharma Conference have a webcast?

No, the session at Leerink Partners Global Biopharma Conference on March 12 will not include a webcast.